Literature DB >> 12196200

Virtual screening: a real screening complement to high-throughput screening.

J Mestres1.   

Abstract

Virtual screening is being routinely used as an integral part of today's hit-identification strategies for, on one hand, prioritizing large corporate screening collections and, on the other hand, to extend the scope of screening to external databases. A brief description of the essential elements required for virtual screening and an application example to the identification of agonist hits for the oestrogen receptor subtype ER alpha are presented.

Entities:  

Mesh:

Year:  2002        PMID: 12196200     DOI: 10.1042/bst0300797

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  7 in total

1.  Design of protein membrane interaction inhibitors by virtual ligand screening, proof of concept with the C2 domain of factor V.

Authors:  Kenneth Segers; Olivier Sperandio; Markus Sack; Rainer Fischer; Maria A Miteva; Jan Rosing; Gerry A F Nicolaes; Bruno O Villoutreix
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-23       Impact factor: 11.205

Review 2.  Novel paradigms for drug discovery: computational multitarget screening.

Authors:  Ekachai Jenwitheesuk; Jeremy A Horst; Kasey L Rivas; Wesley C Van Voorhis; Ram Samudrala
Journal:  Trends Pharmacol Sci       Date:  2008-01-10       Impact factor: 14.819

3.  An improved scoring function for suboptimal polar ligand complexes.

Authors:  Giovanni Cincilla; David Vidal; Miquel Pons
Journal:  J Comput Aided Mol Des       Date:  2008-10-09       Impact factor: 3.686

4.  A network-based multi-target computational estimation scheme for anticoagulant activities of compounds.

Authors:  Qian Li; Xudong Li; Canghai Li; Lirong Chen; Jun Song; Yalin Tang; Xiaojie Xu
Journal:  PLoS One       Date:  2011-03-22       Impact factor: 3.240

5.  Scoring functions and enrichment: a case study on Hsp90.

Authors:  Chrysi Konstantinou-Kirtay; John B O Mitchell; James A Lumley
Journal:  BMC Bioinformatics       Date:  2007-01-26       Impact factor: 3.169

6.  Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores.

Authors:  Nathalie Lagarde; Solenne Delahaye; Jean-François Zagury; Matthieu Montes
Journal:  J Cheminform       Date:  2016-09-06       Impact factor: 5.514

7.  Break Down in Order To Build Up: Decomposing Small Molecules for Fragment-Based Drug Design with eMolFrag.

Authors:  Tairan Liu; Misagh Naderi; Chris Alvin; Supratik Mukhopadhyay; Michal Brylinski
Journal:  J Chem Inf Model       Date:  2017-04-04       Impact factor: 4.956

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.